We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.1B
AUM Growth
-$345M
Cap. Flow
-$330M
Cap. Flow %
-29.93%
Top 10 Hldgs %
62.04%
Holding
493
New
354
Increased
33
Reduced
21
Closed
79

Top Buys

Rank Stock Value
1
RUN icon
Sunrun
RUN
+$95.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$79.4M
3
META icon
Meta Platforms (Facebook)
META
+$73.9M
4
MSFT icon
Microsoft
MSFT
+$73.7M
5
AMZN icon
Amazon
AMZN
+$65.6M

Sector Composition

Rank Sector Weight
1 Technology 24.37%
2 Communication Services 21.75%
3 Consumer Discretionary 16.84%
4 Energy 9.76%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DINO icon
126
CALL
HF Sinclair
DINO
$15.1B
$626K 0.06%
+17,500
New +$585K
SBRA icon
127
Sabra Healthcare REIT
SBRA
$5.28B
$620K 0.06%
+35,731
New +$628K
ARW icon
128
Arrow Electronics
ARW
$10.4B
$619K 0.06%
+5,590
New +$581K
PINS icon
129
Pinterest
PINS
$13.7B
$616K 0.06%
+8,327
New +$619K
CALM icon
130
Cal-Maine
CALM
$3.87B
$613K 0.06%
+15,945
New +$627K
XOM icon
131
ExxonMobil
XOM
$658B
$610K 0.06%
10,920
-980
-8% -$51.4K
AIV
132
Aimco
AIV
$374M
$606K 0.06%
+98,631
New +$500K
RUN icon
133
CALL
Sunrun
RUN
$2.41B
$605K 0.05%
+10,000
New +$695K
HEI icon
134
HEICO Corp
HEI
$51.1B
$600K 0.05%
+4,768
New +$613K
PRSP
135
DELISTED
Perspecta Inc. Common Stock
PRSP
$599K 0.05%
+20,617
New +$581K
CUBI icon
136
Customers Bancorp
CUBI
$2.76B
$595K 0.05%
+18,688
New +$492K
RAMP icon
137
LiveRamp
RAMP
$2.3B
$592K 0.05%
+11,417
New +$778K
RYN icon
138
Rayonier
RYN
$6.49B
$585K 0.05%
+19,984
New +$589K
GWW icon
139
W.W. Grainger
GWW
$60.7B
$578K 0.05%
+1,442
New +$557K
LOB icon
140
Live Oak Bancshares
LOB
$1.94B
$574K 0.05%
+8,378
New +$440K
OHI icon
141
Omega Healthcare
OHI
$14.3B
$570K 0.05%
+15,552
New +$572K
SWBI icon
142
Smith & Wesson
SWBI
$636M
$568K 0.05%
+32,570
New +$592K
BIO icon
143
Bio-Rad Laboratories Class A
BIO
$9.4B
$560K 0.05%
+981
New +$581K
MRNA icon
144
Moderna
MRNA
$23.8B
$560K 0.05%
+4,275
New +$619K
UCTT
145
Ultra Clean Holdings
UCTT
$3.81B
$558K 0.05%
+9,608
New +$442K
IMKTA icon
146
Ingles Markets
IMKTA
$1.65B
$556K 0.05%
+9,017
New +$472K
OPI
147
DELISTED
Office Properties Income Trust
OPI
$547K 0.05%
+19,890
New +$515K
IT icon
148
Gartner
IT
$12.1B
$545K 0.05%
+2,987
New +$519K
EVR icon
149
Evercore
EVR
$11.4B
$543K 0.05%
+4,119
New +$503K
FANG icon
150
Diamondback Energy
FANG
$55.4B
$543K 0.05%
+7,383
New +$506K

Similar funds

Caxton Associates (New York)'s Q1 2021 Portfolio in Review

As of Q1 2021, Caxton Associates (New York) held 493 positions worth $1.1B, down 24% from $1.45B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Caxton Associates (New York) withdrew a net $330M in Q1 2021, closing 79 positions and reducing 21 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $81.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 9.8% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Sunrun worth $83.1M.

  • Caxton Associates (New York)'s largest Q1 2021 buy was Sunrun: 1,374,100 shares worth $83.1M.
  • Caxton Associates (New York) added most to Microsoft in Q1 2021, an estimated $73.7M increase.
  • Caxton Associates (New York)'s biggest Q1 2021 reduction was SPDR Gold Trust, cutting an estimated $382M.
  • Caxton Associates (New York) fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $81.3M.
  • Caxton Associates (New York)'s ten largest holdings make up 62% of its $1.1B portfolio in Q1 2021.
  • Caxton Associates (New York) opened 354 new positions and closed 79 in Q1 2021.
  • Caxton Associates (New York)'s portfolio value fell 24% quarter-over-quarter to $1.1B.

Based on Caxton Associates (New York)'s 13F filing for Q1 2021, filed 17 May 2021.